 WALTHAM, Mass., Sept. 09, 2021 GLOBE NEWSWIRE -- TScan Therapeutics, Inc. Nasdaq: TCRX, a biopharmaceutical company focused on the development of T-cell receptor TCR engineered T cell therapies TCR-T for the treatment of patients with cancer, today announced that Zoran Zdraveski, J.D., Ph.D. has been appointed as Chief Legal Officer. 